Practical Updates in Lymphoma
Lymphomas are highly heterogeneous, consisting of numerous clinicopathologic subtypes and variants whose diagnosis and classification require integration of histologic, immunophenotypic, clinical, molecular and genomic parameters. Furthermore, there is rapid evolution of molecular prognostic factors and therapeutic markers that have clinical impact and challenge pathologists. This interactive microscopy course, supplemented by lectures, highlights the practical aspects of important changes impacting the diagnostic approach to indolent and aggressive B cell lymphomas, Hodgkin lymphoma and T cell lymphoma.
• Improve ability to diagnose indolent and aggressive B cell lymphomas, Hodgkin Lymphoma
and T cell lymphoma
• Refine skills related to the use of immunohistochemical and molecular studies to identify clinically
relevant subtypes of indolent and aggressive B cell lymphomas and T cell lymphomas
• Enhance ability to distinguish diffuse large B cell lymphomas (DLBCLs) from
other aggressive B cell lymphomas
• Better distinguish Hodgkin lymphoma from other B or T cell lymphomas
• Enhance capability of evaluating lymphomas for clinically relevant targeted therapy
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 17.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 15.5 SAM credit hours.